Glucose Serum Concentrations and Cardiovascular Disease in Patients on the End Stage of Renal Disease without Diabetes Mellitus

By Raikou Vaia D.   Kyriaki Despina  

Journal of Cardiovascular Development and Disease, Vol. 2, Iss. 2, 2015-04 ,pp. : 66-75

MDPI

Access to resources Recommend Favorite

Effects of Decreased Vitamin D and Accumulated Uremic Toxin on Human CYP3A4 Activity in Patients with End-Stage Renal Disease

By Tsujimoto Masayuki   Nagano Yui   Hosoda Satomi   Shiraishi Asuka   Miyoshi Ayaka   Hiraoka Shima   Furukubo Taku   Izumi Satoshi   Yamakawa Tomoyuki   Minegaki Tetsuya   Nishiguchi Kohshi  

Toxins, Vol. 5, Iss. 8, 2013-08 ,pp. : 1475-1485

MDPI

Access to resources Recommend Favorite

Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine

By Hüsing Anna   Kabar Iyad   Schmidt Hartmut H.   Heinzow Hauke S.  

International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-08 ,pp. : 18033-18053

MDPI

Access to resources Recommend Favorite

Genomic Damage in Endstage Renal Disease—Contribution of Uremic Toxins

By Schupp Nicole   Heidland August   Stopper Helga  

Toxins, Vol. 2, Iss. 10, 2010-10 ,pp. : 2340-2358

MDPI

Access to resources Recommend Favorite

Association between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel Disease

By Prieto-Pérez Rocío   Almoguera Berta   Cabaleiro Teresa   Hakonarson Hakon   Abad-Santos Francisco  

International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. : 225-225

MDPI

Access to resources Recommend Favorite